Response to: &apos;Riociguat in systemic sclerosis: a potential for disease modification&apos; by Jain and Dhir.

Khanna, Dinesh; Distler, Oliver

doi:10.1136/annrheumdis-2020-218194

Record: found
Abstract: not found
Article: not found

Response to: 'Riociguat in systemic sclerosis: a potential for disease modification' by Jain and Dhir.

Author(s): Dinesh Khanna ¹ , Oliver Distler ²

Publication date (Electronic): July 2022

Journal: Annals of the rheumatic diseases

Publisher: BMJ

Keywords: riociguat, skin fibrosis, systemic sclerosis

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ann Rheum Dis

Title: Annals of the rheumatic diseases

Publisher: BMJ

ISSN (Electronic): 1468-2060

ISSN (Print): 0003-4967

Publication date (Electronic): July 2022

Volume: 81

Issue: 7

Affiliations

[1 ] Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA khannad@med.umich.edu.

[2 ] Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.

Article

Publisher Item ID: annrheumdis-2020-218194

DOI: 10.1136/annrheumdis-2020-218194

PubMed ID: 32669303

SO-VID: a0080105-4268-451b-af51-1a8da593d7fe

History

Keywords: riociguat,skin fibrosis,systemic sclerosis

Data availability:

Keywords: riociguat, skin fibrosis, systemic sclerosis

Comments

Comment on this article

scite_